CDC overrules its advisors, backing COVID booster for health workersThe Centre for Disease Control and Prevention (CDC) in the US has backed booster doses of Pfizer and Share XCDC overrules its advisors, backing COVID booster for health workershttps://pharmaphorum.com/news/cdc-overrules-its-advisors-backing-covid-booster-for-health-workers/
FDA approves Pfizer COVID booster jabs for higher-risk groupsJust days after its advisory committee meeting voted to approve a third dose of Pfizer and BioNTech’s COVID-19 Share XFDA approves Pfizer COVID booster jabs for higher-risk groupshttps://pharmaphorum.com/news/fda-approves-pfizer-covid-booster-jabs-for-higher-risk-groups/
Amnesty says COVID jab producers are causing human rights crisisAmnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not Share XAmnesty says COVID jab producers are causing human rights crisishttps://pharmaphorum.com/news/amnesty-says-covid-jab-producers-are-causing-human-rights-crisis/
Pfizer, BioNTech prep low-dose COVID jab filing for kids aged 5 to 11With positive phase 2/3 results for their COVID-19 vaccine Comirnaty in hand for the five to 11 age Share XPfizer, BioNTech prep low-dose COVID jab filing for kids aged 5 to 11https://pharmaphorum.com/news/pfizer-biontech-prep-low-dose-covid-jab-filing-for-kids-aged-5-to-11/
EU panel rejects Pfizer’s tanezumab for osteoarthritis painAny lingering hope that Pfizer may finally get a regulatory approval for its nerve growth factor (NGF) inhibitor Share XEU panel rejects Pfizer’s tanezumab for osteoarthritis painhttps://pharmaphorum.com/news/eu-panel-rejects-pfizers-tanezumab-for-osteoarthritis-pain/
Ahead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dipsPfizer and Moderna have both reported data that they say backs up the need for booster shots of Share XAhead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dipshttps://pharmaphorum.com/news/ahead-of-fda-adcomm-pfizer-moderna-say-covid-jab-efficacy-dips/
EFPIA: Partnership is the key to healthcare’s biggest challengesThe European pharma body’s new Health Collaboration Guide hopes to inspire greater partnership working across healthcare, showcasing award-winning Share XEFPIA: Partnership is the key to healthcare’s biggest challengeshttps://pharmaphorum.com/sales-marketing/efpia-pharma-healthcare-partnership-guide/
ObsEva files uterine fibroid drug in US, chasing AbbVie, MyovantSwiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in Share XObsEva files uterine fibroid drug in US, chasing AbbVie, Myovanthttps://pharmaphorum.com/news/obseva-filed-uterine-fibroid-drug-in-us-chasing-abbvie-myovant/
UK poised to announce booster COVID jabs for over-50sThe UK government is due to announce a large-scale booster vaccine campaign against COVID-19 for all adults aged Share XUK poised to announce booster COVID jabs for over-50shttps://pharmaphorum.com/news/uk-poised-to-announce-booster-covid-jabs-for-over-50s/
